Mr. Chair, I'll highlight two points.
One, with regard to the regulatory efficiencies we put in place and the dedicated teams that allowed for the expedited approval while maintaining safety standards, we have put forward for consultation now an agile regulation package that takes the best of the lessons from that experience and proposes to adopt those in our food and drug regulations.
The second point, as we've discussed, is securing the commitment to collect, share and use, with the appropriate privacy protections, health data to support the needs of Canadians, both in public health emergencies and in the health care system. We are resolute on advancing on that point.